Politics: Drug price controls would limit new medicines

Premier League transfer news live, today! Latest updates on the summer window

  Premier League transfer news live, today! Latest updates on the summer window We are set for a very busy summer of transfer activity, as the latest transfer news keeps flooding in and plenty of big names are expected to be on the move in the coming months. Your browser does not support this video [ VIDEO: Premier League analysis ] The 2022 summer transfer window opens on June 10 and closes at 6pm ET on September 1. With Erling Haaland already signing for Manchester City, Kylian Mbappe staying at PSG (for now), plus Sadio Mane leaving Liverpool — and plenty of other superstars in demand and contemplating moves — this feels like it will be a summer like no other.

  Drug price controls would limit new medicines © Provided by Washington Examiner

The Democrats' budget reconciliation bill is winding its way through the Senate.

Last week, Republican and Democratic senators met with the chamber's parliamentarian to discuss whether the bill's proposal for Medicare to negotiate the price of prescription drugs with manufacturers has a direct impact on government spending or tax revenue, as reconciliation rules require.

But these are not negotiations. They're price controls. The bill's text sets maximum prices that the government will pay — and threatens confiscatory taxes for drug companies that refuse to comply. That may be politically popular. But it will mean that fewer cutting-edge drugs are available to American patients.

FDA-Induced Shortages Are Nothing New | Opinion

  FDA-Induced Shortages Are Nothing New | Opinion Our food and drug laws are supposed to put Americans first, not consultants, lobbyists, and attorneys for corporate interests.While boasting about military flights importing inconsequential amounts of baby formula, Health and Human Services Secretary Xavier Becerra stated that European baby formula is just as "safe and nutritious" as American baby formula. What he left out is the fact that FDA programs have been banning parents from buying it, even going as far as destroying it at the border, while babies risked starvation and even went to the emergency room.

Further, price controls on prescription drugs are unnecessary. Even as the price of just about everything else in our economy has soared in the past year, drug prices have been relatively flat. According to the latest federal data, consumer prices rose 9.1% between June 2021 and June 2022. Groceries are up 10.4%. Food away from home costs 12.2% more than it did last year. Airline fares increased by 34.1% since last year. Oil prices have nearly doubled. Prescription drug prices, meanwhile, have risen just 2.5% over the last year.

That's partially because nearly 9 in 10 U.S. prescriptions are inexpensive generic medications. That helps keep overall costs to patients down. In 2020, generics saved the U.S. healthcare system over $330 billion. Defenders of negotiations point to nations like Canada that cap the price of medications as models for the U.S. But those price controls have a steep cost. Many cutting-edge medications simply aren't available in countries with price controls, such as Canada, the United Kingdom, and France. For example, Canadian patients have access to just 59% of new cancer drugs launched between 2011 and 2018. U.S. patients have access to 96% of these medicines.

New Drug About 10 Times Stronger Than Fentanyl Circulating in Colorado

  New Drug About 10 Times Stronger Than Fentanyl Circulating in Colorado Police have urged residents to immediately contact law enforcement if they come into contact with anything resembling the drug. Meanwhile, narcotics investigators with the Denver Police Department said they have so far found "minimal amounts" of Pyro in Denver, news station KDVR reported.Like other opioid overdoses, a Pyro overdose causes the potentially fatal symptom of respiratory depression, according to KKCO. However, the new drug is responsive to Naloxone, which is used to treat narcotic overdoses in emergency situations.

If lawmakers want to reduce patient drug costs meaningfully, they should train their focus on pharmacy benefit managers — the industry middlemen insurers hire to negotiate drug prices on their behalf. PBMs typically demand big discounts and rebates from manufacturers as a condition of listing a drug on their formularies. That has the effect of driving list prices up, even as the net price the manufacturer receives declines. PBMs keep a cut of the savings they extract and send another cut to the insurer, which may use that cut to lower overall premiums.

Patients, meanwhile, face cost-sharing obligations based on list prices that have no connection to what their insurer actually pays for a drug. They really ought to share in the savings their PBM extracts.

Inflation data indicate that drug prices are not the problem Democrats make them out to be. Their proposed remedy for this "problem" would have disastrous consequences.

Democrats rev up high-stakes final push to lower drug prices

  Democrats rev up high-stakes final push to lower drug prices Senate Democrats are making a high-stakes final push to get legislation to lower prescription drug prices over the goal line. While much of President Biden’s original economic package, from climate measures to higher taxes on the rich, has been stripped out by Sen. Joe Manchin (D-W.Va.), the party is trying to salvage a major measure…While much of President Biden’s original economic package, from climate measures to higher taxes on the rich, has been stripped out by Sen. Joe Manchin (D-W.Va.), the party is trying to salvage a major measure to lower the cost of prescription drugs that Manchin said he would back.

Sally C. Pipes is president, CEO, and Thomas W. Smith fellow in Health Care Policy at the Pacific Research Institute. Her latest book is False Premise, False Promise: The Disastrous Reality of Medicare for All (Encounter 2020). Follow her on Twitter @sallypipes.

Washington Examiner Videos

Tags: Drug Policy, Opinion, Beltway Confidential, Blog Contributors

Original Author: Sally Pipes

Original Location: Drug price controls would limit new medicines

Kremlin poker-faced on US swap offer to free Griner, Whelan .
MOSCOW (AP) — The Kremlin warned Thursday that a possible prisoner swap with the United States involving American basketball star Brittney Griner needs to be negotiated quietly without fanfare. U.S. Secretary of State Antony Blinken said Wednesday that Washington had offered Russia a deal that would bring home Griner and another jailed American, Paul Whelan. A person familiar with the matter said the U.S. government proposed trading convicted Russian arms dealer Viktor Bout for Whelan and Griner.

See also